إعلان
إعلان
OTLK
Outlook Therapeutics, Inc. Common Stock
0.59
USDبرعاية
+0.06
+10.86%
٠٧ يناير, ١٦:٠٠ UTC -5
مغلق
بعد الإغلاق
0.57
-0.01
-2.39%
تقارير أرباح OTLK
النسبة الإيجابية المفاجئة
OTLK تفوق 18 من 35 آخر التقديرات.
51%
التقرير التالي
بيانات التقرير القادم
١٢ فبراير ٢٠٢٦
Estimate for Q1 26 (Revenue/ EPS)
$3.88M
/-$0.18
التغير الضمني من Q4 25 (Revenue/ EPS)
-4313.04%
/-5.26%
التغير الضمني من Q1 25 (Revenue/ EPS)
--
/-125.00%
Outlook Therapeutics, Inc. Common Stock earnings per share and revenue
On ١٩ ديسمبر ٢٠٢٥, OTLK reported earnings of -0.19 USD per share (EPS) for Q4 25, beating the estimate of -0.25 USD, resulting in a 26.47% surprise. Revenue reached -92000, compared to an expected 5.97 مليون, with a -101.54% difference. The market reacted with a -2.90% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 4 المحللين forecast an EPS of -0.18 USD, with revenue projected to reach 3.88 مليون USD, implying an نقصان of -5.26% EPS, and نقصان of -4313.04% in Revenue from the last quarter.
الأسئلة الشائعة
What were Outlook Therapeutics, Inc. Common Stock's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Outlook Therapeutics, Inc. Common Stock reported EPS of -$0.19, beating estimates by 26.47%, and revenue of $-92.00K, -101.54% below expectations.
How did the market react to Outlook Therapeutics, Inc. Common Stock's Q4 2025 earnings?
The stock price moved down -2.9%, changed from $2.07 before the earnings release to $2.01 the day after.
When is Outlook Therapeutics, Inc. Common Stock expected to report next?
The next earning report is scheduled for ١٢ فبراير ٢٠٢٦.
What are the forecasts for Outlook Therapeutics, Inc. Common Stock's next earnings report?
Based on 4
المحللين, Outlook Therapeutics, Inc. Common Stock is expected to report EPS of -$0.18 and revenue of $3.88M for Q1 2026.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان